SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Prism Medico And Pharmacy informs about press release

20 Feb 2023 Evaluate
Prism Medico And Pharmacy has informed that it enclosed the Pre Offer Advertisement in terms of Regulation 18 (7) of SEBI SAST (Regulations), 2011 hard and soft copy being issued by the company on behalf of Acquirers with regard to open offer for acquisition of Equity Shares of Prism Medico and Pharmacy (Target Company) by Acquirers which was published on 20th February, 2023 in Financial Express - English Daily (all editions); Jansatta - Hindi Daily (all editions); Pratahkal - Marathi Daily (Mumbai edition); Aapka Faisla - Shimla Edition covers Sirmour.

The above information is a part of company’s filings submitted to BSE.

Prism Medico Share Price

27.08 -1.32 (-4.65%)
15-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 242.90
Amrapali Industries 36.84
Adani Enterprises 2942.85
Rashi Peripheral 561.50
PDS 320.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: